OR WAIT null SECS
March 27, 2020
The transgenic mouse R&D platform will support the discovery of fully-human monoclonal antibodies.
March 06, 2020
The acquisition will expand Nexelis’ immunology testing expertise.
February 28, 2020
Eurofins DiscoverX partners with VelaLabs to enable VelaLabs to perform highly reproducible potency lot release assays under GLP/GMP conditions.
February 02, 2020
Data management is crucial in bio/pharmaceutical laboratory settings from discovery steps through clinical studies and varies based on the development phase.
January 31, 2020
The partners will collaborate on developing scale-up chip-based technology to enable commercial-scale production of a third-generation DNA synthesis platform.
The license gives Daiichi Sankyo access to ERS Genomics’ genome-editing technology for internal R&D initiatives.
The company’s new Milliflex Oasis System provides enhanced result reliability, increased productivity, and advanced traceability.
Otsuka will use PhoreMost’s phenotypic screening platform to identify new targets for drug development, with a focus on gene therapy.
January 06, 2020
The Ireland-based company can now offer complete elemental impurities testing services.
The new GMP conditioning product offering is designed to support clinical phase and commercialization stages of cell and gene therapy production.